{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-002774","form_type":"8-K","ticker":"CDT","cik":"0001896212","company_name":"CDT Equity Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.407351+00:00","generated_at":"2026-05-23T21:23:18.855672+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Conduit Pharmaceuticals enters AI analytics deal for AstraZeneca assets; issues 2.26M shares","bullets":["Entered additional agreement with Sarborg for AI analysis of AZD1656, AZD5658, AZD5904 clinical data to identify repurposing opportunities.","Agreement term six months, total consideration $2.0M (cash or stock at company's election).","Issued 1,853,933 shares to satisfy ~$1.65M of fees; also issued 410,113 shares for consulting services.","Company had 9,549,800 shares outstanding as of March 31, 2025.","Aim is to re-evaluate failed endpoints from AstraZeneca trials to identify benefited patient subgroups."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-002774","json":"https://secwatch.observer/filing/0001641172-25-002774.json","markdown":"https://secwatch.observer/filing/0001641172-25-002774.md","text":"https://secwatch.observer/filing/0001641172-25-002774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225002774/0001641172-25-002774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225002774/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T21:23:18.855672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}